✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Quinagolide is an investigational drug.
There have been 4 clinical trials for Quinagolide. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2008.
The most common disease conditions in clinical trials are Ovarian Hyperstimulation Syndrome, Endometriosis, and Syndrome. The leading clinical trial sponsors are Ferring Pharmaceuticals, Instituto Valenciano de Infertilidad, IVI VALENCIA, and [disabled in preview].
Recent Clinical Trials for Quinagolide
|Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis||Ferring Pharmaceuticals||Phase 2|
|Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain||Ferring Pharmaceuticals||Phase 2|
|Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome||Instituto Valenciano de Infertilidad, IVI VALENCIA||Phase 2|